2019
DOI: 10.1136/bmjopen-2019-031020
|View full text |Cite
|
Sign up to set email alerts
|

Patient experience of treatment decision making for wet age-related macular degeneration disease: a qualitative study in China

Abstract: ObjectivesThis study aimed to investigate the experience of patients with wet age-related macular degeneration (wAMD) in treatment decision-making process.DesignA descriptive qualitative study was designed by using semistructured interviews, and the data analysis was conducted with the thematic analysis approach.Participants and settingA convenient and purposive sample of 21 participants diagnosed with wAMD was recruited from May 2018 to September 2018. The study was conducted in the Eye Clinic of Southwest Ho… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4

Citation Types

1
14
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 10 publications
(15 citation statements)
references
References 39 publications
1
14
0
Order By: Relevance
“…Several available publications in the ophthalmological field directed towards managing patients with cataract, diabetic retinopathy, glaucoma, age-related macular degeneration, and exotropia in providing a qualitative analysis by using standard interviews with healthcare workers and/or patients [25][26][27][28][29] and support the need for more patient involvement in shared making decision process. So far, none of these studies aimed to estimate the outcome of the SDM on the patients' satisfaction with the final/post-op result.…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…Several available publications in the ophthalmological field directed towards managing patients with cataract, diabetic retinopathy, glaucoma, age-related macular degeneration, and exotropia in providing a qualitative analysis by using standard interviews with healthcare workers and/or patients [25][26][27][28][29] and support the need for more patient involvement in shared making decision process. So far, none of these studies aimed to estimate the outcome of the SDM on the patients' satisfaction with the final/post-op result.…”
Section: Introductionmentioning
confidence: 99%
“…Median (95% CI) 23(19)(20)(21)(22)(23)(24)(25)(26) 23 (23-28) 27 (24-34) 25(23)(24)(25)(26)(27)(28)(29)(30)(31)(32)(33) …”
mentioning
confidence: 99%
“…Age‐related macular degeneration (AMD) is one of the leading causes of vision loss, and eventually results in blindness 1 . As estimated in 2015 by the Vision Loss Expert Group, AMD ranked fourth among the major causes of blindness globally 2,3 . It is forecasted that the prevalence of AMD will increase further with an increasingly aging population.…”
Section: Introductionmentioning
confidence: 99%
“…It is forecasted that the prevalence of AMD will increase further with an increasingly aging population. Moreover, the severe impact of AMD on the quality of life leads to a substantial social and financial burden 2 . Therefore, the efficient screening and monitoring of AMD allow for better management is of great importance.…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation